Effects of Intermittent Fasting on Patients with Immune Thrombocytopenia (ITP) Receiving TPO-RA : Multicenter Mixed-Design Study

被引：0
|
作者：
Yassin, Mohamed A. [1 ]
Al-Rasheed, Mona [2 ]
Al-Eisa, Taghred [3 ]
Al-Hashim, Nora [4 ]
Al Sayegh, Faisal [4 ]
Abu Zaid, Tarek [5 ]
Musa, Heba [6 ]
Alshurafa, Awni [7 ]
Abdelfattah, Mohamed [8 ]
机构：
[1] Natl Ctr Canc Care & Res, Hematol BMT, Doha, Qatar
[2] Hematol Adan Hosp, Kuwait, Kuwait
[3] Jahra Hosp, Hematol Sect, Kuwait, Kuwait
[4] Mubarak Hosp, Hematol, Kuwait, Kuwait
[5] Al Mowasat Hosp, Hematol, Riyadh, Saudi Arabia
[6] Accsight, Cairo, Egypt
[7] Natl Ctr Canc Care Res, Dept Hematol & Bone Marrow Transplant, Doha, Qatar
[8] Accsight, Jeddah, Saudi Arabia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182824
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 36 条
  • [1] SWITCHING THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS: A RETROSPECTIVE CASE SERIES
    Cantoni, S.
    Carpenedo, M.
    Coccini, V.
    Cairoli, R.
    Pogliani, E. M.
    HAEMATOLOGICA, 2015, 100 : 569 - 569
  • [2] Effects of Ramadan Fasting on Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag
    Yassin, Mohamed A.
    Alasmar, Aya
    Chandra, Prem
    Ismail, Omer
    Nashwan, Abdulqadir Jeprel
    Sideeg, Deena
    Ghori, Firdous
    Hamad, Anas
    Ghasoub, Rola
    BLOOD, 2020, 136
  • [3] CONNECTIVE TISSUE METABOLITES AND CYTOKINES IN IMMUNE THROMBOCYTOPENIA (ITP) TREATED WITH THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA)
    Ghanima, W.
    Boiocchi, L.
    Junker, P.
    Lee, S.
    Feng, X.
    Orazi, A.
    Gudbrandsdottir, S.
    Hasselbalch, H.
    Bussel, J.
    HAEMATOLOGICA, 2012, 97 : 199 - 199
  • [4] Comparison of treatment characteristics between patients diagnosed with immune thrombocytopenia (ITP) and treated with thrombopoietin receptor agonists (TPO-RA).
    Lokhandwala, Tasneem
    Bhor, Menaka
    Stafkey-Mailey, Dana
    Chen, Herman
    Elliott, Brian Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study
    Guillet, Stephanie
    Crickx, Etienne
    Azzaoui, Imane
    Chappert, Pascal
    Boutin, Emmanuelle
    Viallard, Jean-Francois
    Riviere, Etienne
    Gobert, Delphine
    Galicier, Lionel
    Malphettes, Marion
    Cheze, Stephane
    Lefrere, Francois
    Audia, Sylvain
    Bonnotte, Bernard
    Lambotte, Olivier
    Noel, Nicolas
    Fain, Olivier
    Moulis, Guillaume
    Hamidou, Mohamed
    Gerfaud-Valentin, Mathieu
    Marolleau, Jean-Pierre
    Terriou, Louis
    Martis, Nihal
    Morin, Anne-Sophie
    Perlat, Antoinette
    Le Gallou, Thomas
    Roy-Peaud, Frederique
    Robbins, Ailsa
    Lega, Jean-Christophe
    Puyade, Matthieu
    Comont, Thibault
    Limal, Nicolas
    Languille, Laetitia
    Zarrour, Anissa
    Luka, Marine
    Menager, Mickael
    Belmondo, Thibault
    Hue, Sophie
    Canoui-Poitrine, Florence
    Michel, Marc
    Godeau, Bertrand
    Mahevas, Matthieu
    BLOOD, 2023, 141 (23) : 2867 - 2877
  • [6] EFFICACY OF LOW DOSE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) AS MAINTENANCE THERAPY IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIA (ITP)
    Carpenedo, M.
    Cantoni, S.
    Pezzatti, S.
    Cairoli, R.
    HAEMATOLOGICA, 2017, 102 : 60 - 60
  • [7] THROMBOPOIETIN-RECEPTOR-AGONISTS (TPO-RA) IN IMMUNE THROMBOCYTOPENIA (ITP): HIGH EFFICACY BUT AT INCREASED RISK OF THROMBOEMBOLIC EVENTS
    Daffini, R.
    D'Adda, M.
    Gramegna, D.
    Passi, A.
    Borlenghi, E.
    Farina, M.
    Cerqui, E.
    Bottelli, C.
    Ferrari, S.
    Rossi, G.
    HAEMATOLOGICA, 2019, 104 : 58 - 58
  • [8] Thrombin-Generating Capacity of Microvesicles (MVs) in Patients with Immune Thrombocytopenia (ITP) before and during Treatment with Thrombopoietin-Receptor Agonists (TPO-RA)
    Garabet, Lamya
    Ghanima, Waleed
    Hellum, Marit
    Sandset, Per Morten
    Bussel, James B.
    Henriksson, Carola E.
    BLOOD, 2018, 132
  • [9] Reversible, recurrent, dose-dependent leukoerythroblastosis associated with use of a thrombopoietin receptor agonist (TPO-RA) in chronic immune thrombocytopenia (ITP)
    Giermasz, A.
    Etzell, J.
    Fogarty, P. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 788 - 788
  • [10] Thrombopoietin Receptor Agonist (TPO-RA) Switch in Adult Primary Immune Thrombocytopenia (ITP) Patients: A Retrospective Collaborative Survey from 8 Italian Hematology Centers
    Cantoni, Silvia
    Carpenedo, Monica
    Mazzucconi, Maria Gabriella
    De Stefano, Valerio
    Ruggeri, Marco
    Vianelli, Nicola
    Zaja, Francesco
    Barcellini, Wilma
    Nichelatti, Michele
    Coccini, Veronica
    Baldacci, Erminia
    Rossi, Elena
    Puglisi, Simona
    Ciminello, Angela
    Cairoli, Roberto
    BLOOD, 2015, 126 (23)
1234